News 06 mar 2023 Mindmaze launches revolutionary device to improve hand recovery after stroke MindMaze, a Vaud-based worldwide leader in AI-powered digital neurotherapeutics, has released its own proprietary medical device called Izar in t...
News 23 nov 2023 biped.ai secures CHF 1.2 million for US expansion and European growth Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.
News 02 ago 2023 Neuchâtel: the new Swiss crypto haven At the heart of Western Switzerland, a revolution is quietly brewing. Where most would expect the bustling financial hubs of Geneva or Zug to spe...
News 03 nov 2021 USD 17.5 million for Aktiia’s 24/7 blood pressure monitor Neuchâtel-based health tech start-up Aktiia raised USD 17.5 million in a Series A funding round led by Draper Esprit.
Global Opportunities 10 dez 2020 What you need to know about the Irish Healthcare Sector Ireland shows true commitment to public healthcare with the majority of its population entitled to free medical care. Yet this brings about many ...
Third Party Event Digitally delivered // BioTrinity 2020 Digitally delivered Greater London United Kingdom
Press Release 15 dez 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...
News 06 out 2022 The Fongit Innovation Fund rewards three deeptech start-ups The Fongit has announced the latest beneficiaries of the FIF. Geneva-based start-ups EBAMed and Terapet have been awarded a seed loan of CHF 100,...
Actualités 11 mai 2021 Le spécialiste vaudois des traitements ophtalmiques Oculis lève $ 57 millions Oculis, société biopharmaceutique spécialisée dans le développement de traitements ophtalmiques innovants, a annoncé la clôture d’un tour de fina...
News 01 dez 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
News 10 ago 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...